Did not become law. It stopped in the House of Representatives's Appropriations Committee on March 7, 2023. The 2023 session has ended.
2023 Regular Session
House Bill 6628
AN ACT CONCERNING MEDICAID COVERAGE OF BIOMARKER TESTING.
What it does
The synopsis the General Assembly published with the bill.
To improve treatments for cancer and other conditions and diseases by approving Medicaid coverage for biomarker testing.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
5 co-sponsors
Christine Palm, Jason Doucette, David Michel, Joshua M. Hall, Kate Farrar
In the Senate
2 co-sponsors
Its course
February 9 to March 7, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action7 actions on 5 days
In the House of RepresentativesFeb 9 to Mar 7 · stopped26 days
Human Services CommitteeFeb 9 to Mar 221 days
Appropriations CommitteeMar 2 to Mar 7 · stopped5 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Feb 9 – Mar 2
- Feb 9Introduced and sent to Human Services Committee
- Feb 10Heard in Human Services Committee
- Mar 2Human Services Committee recommended it and sent it to Appropriations Committee
All 7 actions, as published
- Feb 9REF. TO JOINT COMM. ONBoth houses
- Feb 10PUBLIC HEARINGBoth houses
- Mar 2Joint Favorable Change of ReferenceBoth houses
- Mar 2FILED WITH LCOBoth houses
- Mar 3RPTD. OUT OF LCOBoth houses
- Mar 3FAV. CHG. OF REF. HOUSE TO COMM. ONHouse of Representatives
- Mar 7FAV. CHG. OF REF., SEN. TO COMM. ONSenate